{"SPADE_UN_17423": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17423", "Peptide Name": "C18-GG-BP100", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GGKKLFKKILKYL", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "C18", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C76H130N18O15", "Mass": 1535.96, "PI": 10.3, "Net Charge": 5, "Hydrophobicity": -0.22, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Synthesis and biological evaluation of novel aliphatic acid-conjugated antimicrobial peptides as potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability", "Pubmed ID": "28831625", "Reference": "Amino Acids. 2017 Nov;49(11)1831-1841.", "Author": "Zhang B, Gu H, Shi W, Li H, Ma G, Chen X, Qian H, Lin H, Huang W, Ge L.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28831625"}], "Frequent Amino Acids": "KLG", "Absent Amino Acids": "ACDEHMNOPQRSTUVW", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 6, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08674", "Similarity": 1.0, "Sequence": "GAAAAGKVVGGKGGK"}, {"SPADE_ID": "SPADE_UN_20730", "Similarity": 1.0, "Sequence": "GAAAAGKVVGGKGGK"}, {"SPADE_ID": "SPADE_UN_22779", "Similarity": 1.0, "Sequence": "WKKIWKPGIKKWIKGGGKK"}]}}}